- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in wockhardt
Wockhardt Unit Ties Up With SII Subsidiary For Manufacturing Plant In UK
A profit-sharing arrangement has been made between the two parties for this new manufacturing facility that will deliver an additional 150 million vaccine doses of multiple vaccines
Read More
Wockhardt Q2 Net Profit Surge Over 11% To Rs 37.17 Cr
The company had posted a net profit of Rs 3.29 crore for the corresponding period of the previous fiscal, Wockhardt said in a regulatory filing.
Read More
UK Extends COVID-19 Vaccine Supply Deal With India's Wockhardt
The agreement is now expanded to August 2022, and Wockhardt will continue to make vaccines at its unit in Wrexham in Wales
Read MoreWockhardt announces Covid-19 vaccine partnership with UK government
Wockhardt announces Covid-19 vaccine partnership with UK government
Read More
Wockhardt To Supply Millions Of Doses Of COVID-19 Vaccines To UK
The company has reserved fill-and-finish capacity - the final manufacturing step of putting vaccines into vials or syringes and packaging them - as part of an agreement with the UK government
Read MoreDr Reddy's net profit falls 13 pc to Rs 579 cr in June quarter
Dr Reddy's net profit falls 13 pc to Rs 579 cr in June quarter
Read More
Wockhardt's Profitability For Q4 Improves To Rs 48 Crore
The earnings before interest, taxes, depreciation and amortisation (EBITDA) for the quarter showed an improvement from Rs 34 crore to Rs 37 crore.
Read More
Wockhardt Back In Black After 3 Years, Stock Jumps 15% Intraday
The company's revenue came in at Rs 869 crore versus Rs 1,046 crore in the same period.
Read More
Pharma: FDA Blues
Indian pharma companies have had to pay a heavy cost for non-compliance with US FDA regulations and post-ban remedial measures using pricey foreign consultants unfamiliar with the country. Now, help is available locally and at a much cheaper cost
Read More-470.jpg)
Skilling Health Care Managers
Until recently, doctors had to double up as administrators at hospitals. Now, with some colleges training managers specifically for the healthcare industry, the doctors can go back to doing what they do best
Read More
Cipla, Wockhardt In Talks For A Broader Business Alliance
The alliance, which may even lead to a merger or equity collaboration between the two drugmakers, is expected to be announced soon
Read More
Cipla, Wockhardt And Pfizer Among Top Winners At DigiPharmaX 2016
The awards recognise the excellence in Digital in the Pharma industry and is the country's first award of this kind
Read More
Drugs Ban | Partial Relief From High Court For Wockhardt, Glaxo And Griffon
The drugs which were subject matter of today's plea are Aceproxyvon, Viscodyne and Viscodyne-D of Wockhardt, Crocin Cold and Flu Max of Glaxo and Grilinctus syrup of Griffon.
Read More
US Regulator Finds Wockhardt Hid Data On Failed Tests
Wockhardt is the latest of several major players in the $15 billion Indian drugs industry to be hit by US regulatory action over the past few months
Read More
FDA Observations Not Critical, Says Wockhardt
The company says none of the nine observations made by the FDA are critical and these issues can be resolved in next 2 to 3 months
Read More